1
|
729-49799665
|
DO 12311433 PEDIDO TRAMITE: OCI-237 DECLARACION(1-1) MERCANCIA NUEVA. ACTA INSPECCION FNE:
|
IMCD COLOMBIA S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2024-07-30
|
UNITED STATES
|
1 Kgs
|
1.00 KG
|
2
|
1512056965
|
DO 32311708 DECLARACION(1-1) FACTURA: 41644078 FECHA: 2023-08-14 LEGALIZACION VOLUNTARIA POR PESO EN DOCUMENTO DE TRANSP
|
COLOMPACK S.A.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2023-08-29
|
INDIA
|
0.29 Kgs
|
0.29 KG
|
3
|
636407580380
|
DIM 1/1, D.O. 03-339/23. NUMERO SOLICITUD: TMR-I-0120719-20230606 DE 2023-06-06, NUMERO VISTO BUENO INVIMA: VINVIMA-23-0
|
CLARIPACK S A
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2023-06-08
|
INDIA
|
0.02 Kgs
|
0.02 KG
|
4
|
6467923195
|
DO BAQI22-2311 , DECLARACION 3 DE 9 , ARANCEL 05 DE ACUEEDO AL DECRETO 272 DE 2018ARTICULO 2, DECRETO 18812021. , PROD
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
UNITED STATES
|
0.01 Kgs
|
0.01 KG
|
5
|
6467923195
|
DO BAQI22-2311 PEDIDO DECLARACION 5 DE 9 ARTICULO 2, DECRETO 1881 2021 , PRODUCTO: OXALATO DE R-CITALOPRAM, NOMBRE C
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
CHINA
|
0.02 Kgs
|
0.02 KG
|
6
|
6467923195
|
DO BAQI22-2311 PEDIDO DECLARACION 2 DE 9 , ARANCEL 05 DE ACUEEDO AL DECRETO 272 DE 2018 ARTICULO 2, DECRETO 18812021 ,
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
CHINA
|
0.01 Kgs
|
0.01 KG
|
7
|
6467923195
|
DO BAQI22-2311 PEDIDO DECLARACION 9 DE 9 ARANCEL 0% DE ACUERDO AL DECRETO 272 DE 2018.ARTICULO 2, DECRETO 1881 2021
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
CANADA
|
0.01 Kgs
|
0.01 KG
|
8
|
6467923195
|
DO BAQI22-2311 PEDIDO DECLARACION 6 DE 9 .ARTICULO 2, DECRETO 1881 2021 , PRODUCTO: ISORHAMNETIN (30 MG), NUMERO DE C
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
INDIA
|
0.13 Kgs
|
0.13 KG
|
9
|
6467923195
|
DO BAQI22-2311 PEDIDO DECLARACION 7 DE 9 ARTICULO 2, DECRETO 1881 2021 , PRODUCTO: OMEPRAZOL (200MG), ESTANDAR PRIMARI
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
FRANCIA
|
0.02 Kgs
|
0.02 KG
|
10
|
6467923195
|
DO BAQI22-2311 PEDIDO DECLARACION 8 DE 9 ARANCEL 0% DE ACUERDO AL DECRETO 272 DE 2018.ARTICULO 2, DECRETO 1881 2021
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
FRANCIA
|
0.01 Kgs
|
0.01 KG
|